Upcoming Live Webinars

  • Includes Credits Includes a Live Web Event on 02/17/2022 at 12:00 PM (EST)

    Bret Scher, MD

    CME/CE Expiration Date: 02/16/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.


    Low-carb and keto diets can help people lose weight and improve their metabolic health. However, many clinicians are concerned with that amount of fat and lack of carbs in low-carb diets and fear they will raise LDL cholesterol and cardiovascular risk.

    However, studies show that, on average, those starting a low-carb or keto diet for weight loss or for treating type 2 diabetes do not see a rise in their LDL. Instead, they see an increase in HDL, decrease in TG, and an improvement in blood sugars and insulin sensitivity. The net result is a decrease in calculated cardiovascular risk. 

    That being said, a minority of people following low-carb diets do see a rise in their LDL, especially the leaner, more physically active individuals. It may be important to approach these individuals differently than a metabolically unhealthy individual on a high-carb diet. Putting the LDL changes into the context of their overall health progress can help reframe how to address their cardiovascular risk.

    In the end, if a clinician wants to help their patient reduce their LDL while still following a low-carb diet for metabolic health and weight loss, numerous strategies exist that may be helpful. These include nutritional changes, supplements, and prescription medications.


    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.